AnalystsJack AllenJack Allen's Stock Forecasts
AnalystsJack Allen
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4204 out of 4241 analysts
Average Return
-27.12%
Win Rate
27%6 out of 22
Risk vs Reward
Poor
Good
Jack Allen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Renovacor IncRCOR | +82.86% | $1.75 | $3.20 | 2022-09-13 - 2022-11-30 | Buy |
Carisma Therapeutics IncCARM | +71.35% | $3.56 | $6.10 | 2023-04-14 - 2023-06-09 | Buy |
Voyager Therapeutics IncVYGR | +60.68% | $3.84 | $6.17 | 2021-10-07 - 2022-10-06 | Buy |
Arcellx IncACLX | +36.96% | $29.30 | $40.13 | 2023-04-13 - 2023-06-09 | Buy |
Arcellx IncACLX | +29.41% | $31.01 | $40.13 | 2023-04-14 - 2023-06-09 | Buy |
Jack Allen Analyst Color
Get additional color on Jack Allen's coverage of popular stocks
Jack Allen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcellx IncACLX | 2 | Buy | $39.00 | -2.82% | Initiates Coverage On | 2 months ago |
Carisma Therapeutics IncCARM | 1 | Buy | $10.00 | +63.93% | Initiates Coverage On | 2 months ago |
Vor Biopharma IncVOR | 2 | Buy | $22.00 | +340.00% | Maintains | 3 months ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $46.00 | -24.89% | Initiates Coverage On | 3 months ago |
Bluebird Bio IncBLUE | 1 | Buy | $10.00 | +173.97% | Initiates Coverage On | 3 months ago |
Intellia Therapeutics IncNTLA | 1 | Hold | $42.00 | -2.87% | Maintains | 4 months ago |
Frequency Therapeutics IncFREQ | 2 | Buy | $4.00 | +952.63% | Maintains | 4 months ago |
Taysha Gene Therapies IncTSHA | 3 | Buy | $6.00 | +597.67% | Maintains | 4 months ago |
Allogene Therapeutics IncALLO | 2 | Buy | $12.00 | +112.77% | Upgrades | 5 months ago |
Instil Bio IncTIL | 4 | Buy | $14.00 | +2,272.88% | Maintains | 7 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Buy | $5.00 | +262.32% | Initiates Coverage On | 7 months ago |
Renovacor IncRCOR | 1 | Buy | $9.00 | +181.25% | Initiates Coverage On | 9 months ago |
Fate Therapeutics IncFATE | 1 | Hold | $28.00 | N/A | Initiates Coverage On | a year ago |
Cellectis SaCLLS | 2 | Buy | N/A | N/A | Upgrades | a year ago |
Mink Therapeutics IncINKT | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Decibel Therapeutics IncDBTX | 1 | Buy | $21.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $9.00 | N/A | Upgrades | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.